Edit

Click Therapeutics®

http://clicktherapeutics.com/

Last activity: 22.05.2024

Active

Categories: BioTechDataHealthTechInformationMedTechOptimizePlatformScienceSmokingSoftware

Click Therapeutics, Inc. is a biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.

Likes

206

Followers

699

Followers

6.77K

Website visits

14.4K /mo.

Mentions

Persons

Location: United States, New York

Employees: 51-200

Total raised: $69M

Founded date: 2012

Founders name: Wei Kiddy Zhou

Founders Related Locations: United States, New York, New York; United States, Washington, Redmond

Twitter

Facebook

Instagram

Investors 6

Date	Name	Website
27.10.2021	H.I.G. Cap...	higcapital...
-	H.I.G. Bio...	higbio.com
-	K2 HealthV...	k2healthve...
-	Supernode ...	supernode....
-	K2 HealthV...	k2hv.com
-	H.I.G. Cap...	hig.com/

Funding Rounds 2

Date	Series	Amount	Investors
22.10.2021	Series B	$52M	H.I.G. Bio...
24.07.2018	-	$17M	-

Persons 1

Date	First Name	Last Name	Title	LinkedIn	Twitter	Email
-	Wei Kiddy	Zhou	Co-Founder...	linkedin.c...	-	-

Mentions in press and media 23

Date	Title	Description
22.05.2024	Click Therapeutics acquires Better Therapeutics assets	figcaption>span]:font-sans"> Click Therapeutics, a provider of prescription treatments via a smartphone, has acquired assets of Better Therapeutics. Why it matters: Several companies have made early headway in the space only to s...
15.04.2024	Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million	-
15.04.2024	Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million	ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases...
29.03.2024	DarioHealth reports decreased revenue following Twill acquisition	Photo: JGI/Tom Grill/Blend Images/Getty Images DarioHealth, a digital chronic-condition-management platform, reported $3.6 million in revenue for Q4 2023, compared to $6.8 million for the fourth quarter of 2022, a 47% decrease. Year-over-ye...
18.03.2024	Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million	-
18.03.2024	Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million	ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases...
03.07.2023	Pharma can’t let Big Tech win the race for medical AI	Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that in...
19.04.2022	Unlearn raises $50M for clinical trial digital twins and more digital health fundings	Photo: Getty Images/filadendron
26.10.2021	H.I.G. BioHealth Partners Co-Leads a $52M Financing for Click Therapeutics	STAMFORD, CT – October 26, 2021 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global alternative investment firm with over $45 billion of equity capital under management,*...
25.10.2021	Click Therapeutics raises $52M, looks to advance digital therapeutics	Less than a year after its last financing, Click Therapeutics raised $52 million to develop its portfolio of software-based treatments. The New York-based startup recently raised a series B round led by H.I.G. BioHealth Partners and Accelme...
25.10.2021	Click Therapeutics lands $52M	Click Therapeutics has raised a $52 million Series B co-led by Accelmed and HIG BioHealth Partners. The New York-based company develops digital prescription medical treatments for patients with chronic pain, autoimmune disorders and other h...
22.10.2021	Click Therapeutics Completes $52 Million Series B Financing Co-Led by H.I.G. BioHealth Partners and Accelmed Partners	Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has closed a $52 million upsized Series B financing. The financing round was co-led by new investors H.I.G. Bi...
22.10.2021	With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more	Another medtech developer's plans to create digital therapeutics to treat a wide range of illnesses are clicking into place, thanks to a third multimillion-dollar investment in Click Therapeutics in barely a year. Click Therapeutics’ latest...
01.12.2020	Click Therapeutics Secures $30M	NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc., a leader in Digital Therapeutics solutions as prescription medical treatments, today announced $30 million in debt financing from K2 HealthVentures (K2HV), a healthcare-focused specialty ...
07.08.2018	Which New York City healthcare companies raised the most dough from investors in Q2?	Thrive Global, the consumer wellness platform headed up by Arianna Huffington, was at the top of the list. In May, it announced it brought in $43 million. Aetion, which focuses on real-world data through the science and analytics platform i...
24.07.2018	Term Sheet — Tuesday, July 24	PE BUBBLE? I read an interesting article titled, “Everything About Private Equity Reeks of Bubble. Party On!” It lays out the concerns of private equity’s record fundraising that’s pushed the industry’s dry powder to more than $1 trillion —...
24.07.2018	Click Therapeutics Raises $17M in Funding	Click Therapeutics, Inc., a New York-based provider of Digital Therapeutics™ solutions as prescription medical treatments, raised $17m in funding. The round was led by Sanofi Ventures. Bernard Davitian, SVP and Managing Director of Sanofi V...
23.07.2018	Sanofi Ventures Leads $17 Million Financing of Click Therapeutics	CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. a leader in Digital Therapeutics solutions as prescription medical treatments, announces a $17 million financing round led by Sanofi Ventures. Click will use this fi...
23.07.2018	Click Therapeutics Lands $17M to Advance Prescription Digital Therapeutics Platform	Click Therapeutics, Inc. (“Click”), a provider of Digital Therapeutics solutions as prescription medical treatments, has raised $17 million in funding led by Sanofi Ventures, the corporate venture capital arm of Sanofi. Sanofi Ventures inve...
08.11.2014	Funding roundup: Using lasers to change eye color from brown to blue, and more.	Biotech Abeona Therapeutics – Cleveland, Ohio $3.6 million in equity raised of a proposed $5 million round Developing treatments for orphan childhood lysosomal storage disease. Its lead candidates, ABX-A and ABX-B, treat Sanfilippo Type A a...
-	Click Therapeutics raises $52M, looks to advance digital therapeutics	Less than a year after its last financing, Click Therapeutics raised $52 million to develop its portfolio of software-based treatments. The New York-based startup recently raised a series B round led by H.I.G. BioHealth Partners and Accelme...
-	Funding roundup: Using lasers to change eye color from brown to blue, and more.	Each week, many millions are invested into life sciences startups. For example, Stroma Medical – a laser therapy company that claims it can swap your eye color from brown to blue – is in the midst of clinical trials and has raised more cash...
-	Which New York City healthcare companies raised the most dough from investors in Q2?	A new report from New York City Health Business Leaders found that during the second quarter of 2018, investors poured more than $300 million into healthcare startups based in the Big Apple. The investment update also provides a closer look...

Click Therapeutics®

Investors 6

Funding Rounds 2

Persons 1

Mentions in press and media 23

Reviews 0